Toxicological Reviews

, Volume 24, Issue 3, pp 153–154 | Cite as

Hyperbaric Oxygen for Carbon Monoxide Poisoning

  • Yedidia BenturEmail author

The main mechanism of carbon monoxide (CO) toxicity is tissue hypoxia. Hence, since 1868, oxygen supplementation has been used as antidotal therapy. As a result of animal studies that suggested a beneficial effect of hyperbaric oxygen (HBO) in CO poisoning, HBO therapy has been implemented in human poisoning as early as 1960. HBO increases the amount of oxygen dissolved in the plasma and diminishes tissue hypoxia by shortening the elimination half-life of carboxyhaemoglobin (COHb), improving oxygen delivery to injured tissues, preventing leukocyte-mediated inflammatory changes and the resulting lipid peroxidation in the brain, and reducing cerebral oedema as a result of vasoconstriction.[1, 2, 3, 4, 5, 6]

The main objectives of HBO therapy are to treat serious end-organ damage (e.g. myocardial ischaemia, coma, seizures) and to prevent the development of persistent and/or delayed neurological sequelae. The strong biological plausibility of the efficacy of normobaric oxygen (NBO) and HBO...



No sources of funding were used to assist in the preparation of this editorial. The author has no conflicts of interest that are directly relevant to the content of this editorial.


  1. 1.
    Weaver LK, Howe S, Hopkins R, et al. Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. Chest 2000; 117(3): 801–8PubMedCrossRefGoogle Scholar
  2. 2.
    Zamboni WA, Roth AC, Russell RC, et al. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 1993; 91(6): 1110–23PubMedCrossRefGoogle Scholar
  3. 3.
    Thom SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol 1993; 123(2): 248–56PubMedCrossRefGoogle Scholar
  4. 4.
    Thom SR, Mendiguren I, Hardy K, et al. Inhibition of human neutrophil beta2-integrin-dependent adherence by hyperbaric O2. Am J Physiol 1997; 272 (3 Pt 1): C770–7PubMedGoogle Scholar
  5. 5.
    Thom SR. Antagonism of carbon monoxide-mediated brain lipid peroxidation by hyperbaric oxygen. Toxicol Appl Pharmacol 1990; 105(2): 340–4PubMedCrossRefGoogle Scholar
  6. 6.
    Nylander G, Lewis D, Nordstrom H, et al. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg 1985; 76(4): 596–603PubMedCrossRefGoogle Scholar
  7. 7.
    Raphael JC, Chevret S, Driheme A, et al. Managing carbon monoxide poisoning with hyperbaric oxygen. Proceedings of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), Strasbourg, France, 2004 Jun 1–4 [abstract 62]. J Toxicol Clin Toxicol 2004; 42(4): 455–6Google Scholar
  8. 8.
    Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002; 347(14): 1057–67PubMedCrossRefGoogle Scholar
  9. 9.
    Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial Med J Aust. 1999; 170(5): 203–10PubMedGoogle Scholar
  10. 10.
    Mathieu D, Wattel F, Mathieu-Nolf M, et al. Interim analysis: controlled clinical trial of hyperbaric oxygen in acute carbon monoxide (CO) poisoning. Undersea Hyperb Med 1996; 23 Suppl.: 7–8Google Scholar
  11. 11.
    Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995; 25(4): 474–80PubMedCrossRefGoogle Scholar
  12. 12.
    Raphael JC, Elkharrat D, Jars-Guincestre MC, et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; II: 414–9CrossRefGoogle Scholar
  13. 13.
    Buckley NA, Isbister GK, Stokes B, et al. Hyperbaric oxygen for carbon monoxide poisoning: a systematic review and critical analysis of the evidence. Toxicol Rev 2005; 24: 75–92PubMedCrossRefGoogle Scholar
  14. 14.
    Domachevsky L, Adir Y, Grupper M, et al. Hyperbaric oxygen in the treatment of Carbon monoxide poisoning. Clin Toxicol 2005; 43: 181–8Google Scholar
  15. 15.
    Weaver LK. Carbon monoxide. In: Dart RC, editor. Medical toxicology. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2004: 1146–53Google Scholar
  16. 16.
    Tomaszewski C. Carbon monoxide. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al., editors. Goldfrank’s toxicologic emergencies. 7th ed. New York: McGraw-Hill, 2002: 1478–91Google Scholar
  17. 17.
    Carbon monoxide. In: Poisindex, Healthcare series vol. 125. Greenwood Village (CO): Thomson Micromedex, 2005Google Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  1. 1.Israel Poison Information Center, Rambam Medical Center, The Bruce Rappaport Faculty of MedicineTechnion HaifaIsrael

Personalised recommendations